SMTI Insider Trading Activity and SEC Form 4 Filings
SMTI insider trading summary
No open-market insider purchases or sales of Sanara MedTech Inc. (SMTI) have been reported on SEC Form 4 in the past 12 months.
Latest SMTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 8, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $14K (417 @ $33.00) |
| Nov 4, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $19K (563 @ $33.00) |
| Nov 2, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $660 (20 @ $33.02) |
| Sep 22, 2022 | Shawn M. Bowman | Pres. - Strategic Partnerships | Sell | $18K (660 @ $27.54) |
| Sep 22, 2022 | Shawn M. Bowman | Pres. - Strategic Partnerships | Sell | $10K (340 @ $28.56) |
| Jul 6, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $17K (750 @ $23.00) |
| Jul 6, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $15K (665 @ $22.00) |
| Jul 5, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $6K (265 @ $21.45) |
| Jun 29, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $6K (294 @ $21.00) |
| Jun 28, 2022 | Zachary B. Fleming | Chief Executive Officer | Sell | $1K (69 @ $21.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.